Skip to main content
ANVS
NYSE Life Sciences

New Patent for Annovis Bio's Buntanetap Expands Treatment Scope for Brain Infections Through 2044

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.27
Mkt Cap
$60.113M
52W Low
$1.11
52W High
$5.5
52W Position info
105% above low
Off High info
59% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ANVS has more than doubled off its 52-week low of $1.11.

Summary

Annovis Bio has secured a U.S. patent for its lead drug candidate, buntanetap, covering its use in preventing and treating neurological injuries caused by brain infections. This patent extends intellectual property protection for buntanetap through 2044 and expands its potential therapeutic applications beyond Alzheimer's and Parkinson's disease, adding value to the company's core asset. This positive IP development provides a much-needed counterpoint amidst recent negative news, including the CFO's departure and the company's 10-K highlighting substantial doubt about its ability to continue as a going concern and a NYSE delisting notice. Investors will continue to monitor the company's financial stability, progress in its Phase 3 clinical trials for AD/PD, and any further developments regarding its NYSE listing.

At the time of this announcement, ANVS was trading at $2.27 on NYSE in the Life Sciences sector, with a market capitalization of approximately $60.1M. The 52-week trading range was $1.11 to $5.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ANVS - Latest Insights

ANVS
Nov 17, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.800
Real-time Price: $0.7539 info
Change: -$0.0461 (-6%) info
Market Cap: $46.994M info
ANVS
Nov 13, 2026, 4:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.940
Real-time Price: $0.7539 info
Change: -$0.1861 (-20%) info
Market Cap: $46.994M info
ANVS
Nov 06, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.8799
Real-time Price: $0.7539 info
Change: -$0.126 (-14%) info
Market Cap: $46.994M info
ANVS
Nov 05, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.8689
Real-time Price: $0.7539 info
Change: -$0.115 (-13%) info
Market Cap: $46.994M info
ANVS
Nov 04, 2026, 5:01 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.7539 info
Change: -$0.1861 (-20%) info
Market Cap: $46.994M info